Chanda Houts, DPM
Podiatrist · Tallassee, ALNPI 1841219078
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Musculoskeletal Transplant Foundation Inc. accounts for 80.4% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2020 at $2,098 and has fallen 95.7% since, to $91 in 2025.
Across 34 payments — averaging $84.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$2K
- Organogenesis Inc.$217
- Amgen$70
- AbbVie$63
- ANI Pharmaceuticals, Inc.$33
- Smith+Nephew$26
- plus $151 from 8 others
What the payments were for
- Speaking & faculty fees$602%
- Food & beverage$2,62592%
- Entertainment$1806%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 12 | $2,305 |
| Organogenesis Inc. | 3 | $217 |
| Amgen(2 entities) | 4 | $70 |
| AbbVie | 4 | $63 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| Smith+Nephew | 2 | $26 |
| Abbott | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| GRT US Holding, Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Ossur Americas, Inc. | 1 | $19 |
| Cardiovascular Systems Inc. | 1 | $18 |
| Bayer | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$113
How this compares
$2,866 in reported general payments places this provider in the 75th percentile of 59 podiatrist providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 29 | $1,056 |
| Gabapentin | 149 | $1,027 |
| Colchicine | 24 | $699 |
| Terbinafine Hcl | 38 | $559 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 19 | $496 |
| Mupirocin | 43 | $345 |
| Amitriptyline Hcl | 11 | $120 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $102 |
| Pregabalin | 13 | $75 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Tallassee
- Michael HamesFlorence$100K
- James MorganMobile$21K
- John RobersonBirmingham$10K
- Kyle MaukBirmingham$10K
- Johnnie AlstonMontgomery$9K
- Heidi ChristieMontgomery$7K
- Brent HaverstockBirmingham$7K
- David LindeBirmingham$6K
- Robert OcampoCullman$5K
- Jamie ClecklerBirmingham$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.